25
2022Cuttsy+Cuttsy
AGENCY STATEMENT
We are a healthcare agency where people matter. We use clarity and conversation to bring healthcare communication to life. Patients are involved as people, clients as partners and employees as peers in our mission to improve access, understanding and engagement across trials, treatments and beyond.

- Agency description
Cuttsy+Cuttsy is a healthcare agency where people matter.
We use clarity and conversation to bring healthcare communication to life. By putting audiences at the heart of our thinking and embedding emotional intelligence into how we work, patients are involved as people, clients as partners and employees as peers in our mission to improve access, understanding and engagement across trials, treatments and beyond. Everything we do is built on a foundation of emotional intelligence and centred around inclusion, user experience, co-creation, sustainability and trust.
And because it's people that matter most, we never lose sight of the fact that they are central to everything we do. It’s why we pride ourselves on developing close and mutually respectful relationships with everyone we work with.
The centre of all this is our team. Awarded ‘We Invest in People: Gold’ from Investors in People, we have a culture built on respect, collaboration and support. And by involvement with the wider community we’re all stronger. We are active members of industry groups such as the BHBIA and Patient Information Forum (PIF), and Caroline, one of our Founders, is co-Chair of the PM Society.
- Contact details
- Unit 6, The Works Unity Campus, London Road Pampisford Cambridgeshire CB22 3FT
- +44 (0)1223 967222
- letstalk@cuttsyandcuttsy.com
- https://www.cuttsyandcuttsy.com/
- Key contact
- Caroline Benson
- Co-founder
- letstalk@cuttsyandcuttsy.com
- +44 (0)1223 967222
- 2022 Agency Data
-
2021 awardsTotal staff25-49 staffBillings from UK creative healthcare workHealthcare staff25-49 staffTotal agency billingsAgency ageBetween 10 and 15 yearsSocial media footprintStatusINDEPENDENTApproximate percentage of advertising, branding, creative or design work in the UK healthcare market60-69%
- This information was supplied or confirmed by Cuttsy+Cuttsy. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
Latest content from Cuttsy+Cuttsy on PMHub
- Cuttsy+Cuttsy campaign takes health literacy to the North Pole
- Our 2022 Christmas campaign saw Santa’s agency elves creating tailored materials for patients. But were the examples guided by the principles of health literacy? Were they naughty or nice?
Cuttsy + Cuttsy - Celebrating award-winning patient-centricity
- Every year, Cuttsy+Cuttsy choose to sponsor 'Patient Programmes' at the PM Society Digital awards. Here's why.
Cuttsy + Cuttsy - Cuttsy+Cuttsy's first EcoVadis rating comes back silver!
- Louise Jones, Sustainability Officer at Cuttsy+Cuttsy celebrates their new silver sustainability rating
Cuttsy + Cuttsy



COVID-19 Updates and Daily News
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
Quick links
Latest intelligence
- Time to talk about health inequalities
- Health inequalities are increasingly being recognised as a crucial healthcare challenge in the UK...
- Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- AstraZeneca’s mild combination asthma reliever approved in UK
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Italy accelerates the path towards digital therapeutics implementation
- Bristol Myers Squibb’s Sotyktu approved by EC for plaque psoriasis
- Positive results for Almirall’s lebrikizumab in atopic dermatitis published in NEJM and BJD
- When to call in the specialists: strategy in Medical Affairs
- Time to talk about health inequalities
- Powering Rapid Cognitive Analysis with AI
- AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma
- Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Positive results for Almirall’s lebrikizumab in atopic dermatitis published in NEJM and BJD
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...